PF-6260933
CAY-29220-50 50 mg
Data Sheet: 
SDS:
SDS:
CAS
1811510-56-1
Formulation
A solid
Purity
≥98%
MW
296,75408
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
A MAP4K4 inhibitor (IC50 = 3.7 nM); selective for MAP4K4 over a panel of 41 kinases at 1 µM but also inhibits TNIK and MINK1 (IC50s = 15 and 8 nM, respectively); inhibits the replication of CMV strains AD169 and Merlin(R1111) strains in HFF cells (EC50s = 9.6 and 13.3 µM, respectively); inhibits collagen- or thrombin-induced aggregation of isolated human platelets by 70.9 and 61.2%, respectively, at 20 µM; decreases plaque formation in ApoE-/- mice fed a Western diet in a model of atherosclerosis at 10 mg/kg; decreases LPS-induced increases in TNF-α levels in wild-type mice and fasting blood glucose levels in ob/ob mice at 15 mg/kg
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).
